Erratum to “First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results” [Breast 36 (Suppl. 1) (November 2017) S44–S45]
Titel:
Erratum to “First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results” [Breast 36 (Suppl. 1) (November 2017) S44–S45]
Auteur:
Janni, Wolfgang Chan, Arlene Nusch, Arnd Alba, Emilio Bachelot, Thomas Gil-Gil, Miguel Kattan, Joseph Bourgeois, Hugues El Karak, Fadi Sutradhar, Santosh Miller, Michelle Chandiwana, David Conte, Pierfranco